Secondary sarcoma of bone post-prostate brachytherapy: A case report
Allison Ye(BC Cancer Agency), Michael McKenzie(Provincial Health Services Authority), Christine Simmons(BC Cancer Agency), Cheng‐Han Lee(National Tsing Hua University), Lorna Weir(BC Cancer Agency), Michael Peacock(BC Cancer Agency), Paul W. Clarkson(University of British Columbia), Jessica L. Conway(BC Cancer Agency)
Cited by 1
Related Papers
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Stereotactic Breast Biopsy of Nonpalpable Lesions: Determinants of Ductal Carcinoma in Situ Underestimation Rates
|Radiology|2001|343
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2017|319
Use of mutation profiles to refine the classification of endometrial carcinomas
|The Journal of Pathology|2012|299